Concepedia

Farzad Rahmani

FR

Statistics

Publications

11

Citations

249

H-Index

10

Active since

2019

Affiliations

Mashhad University of Medical Sciences(Current)

Brighton and Sussex Medical School

Iranshahr University

Washington University in St. Louis

University of Helsinki

Farzad Rahmani is an author at Mashhad University of Medical Sciences specializing in medicine, molecular oncology, and colorectal cancer.

ORCID

Publications per year

2019–2023

11

Publications

11

RETRACTED: Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K/AKT and NF-κB signaling pathways

Farzad Rahmani, Fereshteh Asgharzadeh, Amir Avan et al. · Life Sciences · 2020 · 53 citations · Full text

, , +14

RETRACTED: Cerium oxide nanoparticles acts as a novel therapeutic agent for ulcerative colitis through anti-oxidative mechanism

Fereshteh Asgharzadeh, Alireza Hashemzadeh, Farzad Rahmani et al. · Life Sciences · 2021 · 41 citations

, , +14

Angiotensin receptor blocker losartan inhibits tumor growth of colorectal cancer

Milad Hashemzehi, Farzad Rahmani, Mahdieh Khoshakhlagh et al. · PubMed · 2020 · 35 citations · Full text

, , +17

RETRACTED: Novel oral transforming growth factor‐β signaling inhibitor potently inhibits postsurgical adhesion band formation

Atena Soleimani, Fereshteh Asgharzadeh, Farzad Rahmani et al. · Journal of Cellular Physiology · 2019 · 20 citations

, , +17

Inhibition of angiotensin II type 1 receptor by candesartan reduces tumor growth and ameliorates fibrosis in colorectal cancer

Ehsan Tabatabai, Majid Khazaei, Fereshteh Asgharzadeh et al. · PubMed · 2021 · 20 citations · Full text

, , +16

1–5 of 11